According to recent numbers, 50% of all Americans are prescribed approximately one pill per day. That’s a lot of people, a lot of pills, and undoubtedly many, many missed doses. These days, remembering to take your pills is often even more difficult than getting them, especially for senior citizens.
Massachusetts-based Vitality, Inc. has [...]
Last week, trial-matching platform developer Healogica announced the availability of a new iPhone app that allows potential patients to search for clinical trials via the mobile web. Only $.99 to download, Clinical Trials 2.0 is an extension of Healogica’s current website, which provides a database for patients to search and connect with trials based [...]
Life sciences took two of the five spots in this week’s Startup Watch from Mass High Tech. The first company spotlighted as one to watch is a unique pharmaceutical company out of Maine called Putney that specializes in drugs for pets. The company says it focuses on developing generics for frequently used drugs where cost [...]
We’ve seen a lot of ink dedicated to cloud computing in the life sciences press over the past six months, so it seems like it is past time to acknowledge the buzz and take a closer look at some of the issues surrounding this latest movement. Genome Technology’s overview of the trend, published today [...]
Everyone likes a great idea, and some have more resources to foster them than others. In a move that pits big business against academia which he termed prone to “academic snobbery”, GlaxoSmithKline Chief Executive Andrew Witty said this week that the company is considering adding new facilities at its main research sites aimed at [...]
Medford based Ancora Pharmaceuticals, former winner of the prestigious 2002 Robert P. Goldberg Business plan contest at MIT, announced this week that the National Institutes of Health (NIH) has awarded the company a $530,000 Phase 1 Small Business Innovation Research grant. The grant supports Ancora’s efforts to develop a vaccine to prevent malaria anemia. [...]
Yesterday, we announced $500,000 in seed funding for new medical software startup RxVantage. The company is growing fast (a 90% acceptance rate of its signature application among early adopters has accelerated outreach), and the investment, which the company hopes will be a part of a much larger ($6-8 million) round within the next few months, [...]